A Mini-Review of Pharmacological and Psychosocial Interventions for Reducing Irritability Among Youth With ADHD

Abstract

Approximately a third of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) experience significant irritability; despite this, no study has reviewed whether interventions for youth with ADHD can improve irritability. This mini review sought to address this gap in the literature by discussing existing pharmacological and psychosocial interventions for irritability among children and adolescents with ADHD. A literature search was conducted in April 2021, with a total of 12 intervention articles identified (six pharmacological, one psychosocial, five combined). Studies were excluded if they did not involve an intervention, a measure of irritability, or the population was not youth with ADHD. Of these articles, two were with an ADHD only sample; seven included ADHD with comorbid disruptive behavior, disruptive mood dysregulation disorder (DMDD), or severe mood dysregulation (SMD); and three included ADHD with comorbid autism spectrum disorder (ASD). Findings suggest that central nervous system stimulants used alone or in combination with behavior therapy are effective at reducing irritability in youth with ADHD only or comorbid ADHD and DMDD/SMD. Less evidence was found for the efficacy of guanfacine and atomoxetine for youth with ADHD only or comorbid ADHD and ASD. Parent training alone or in combination with atomoxetine was found to be effective at reducing irritability in youth with comorbid ADHD and ASD. Future research assessing the efficacy of other psychosocial interventions, particularly cognitive behavioral therapy is necessary, as are randomized trials assessing intervention sequencing and intensity among youth with ADHD. Researchers are advised to utilize well-validated measures of irritability in future research.

Transcranial random noise stimulation combined with cognitive training for treating ADHD: a randomized, sham-controlled clinical trial

“…Current gold-standard treatments for ADHD symptoms include pharmacological treatments, psychosocial interventions, or their combination [ 15 , 16 ]. Despite their proven efficacy, they are associated with a range of side effects and relatively poor adherence [ 17 ], and have potentially limited long-lasting effects [ 15 , 18 , 19 ]. There is therefore a pressing need for developing and testing novel, non-pharmacological interventions for ADHD.…”

Transcranial Random Noise Stimulation combined with Cognitive Training for Treating ADHD: A Randomized, Sham-Controlled Clinical Trial

“…Current gold-standard treatments to ADHD include pharmacological treatments, psychosocial interventions, or their combination [10]. Despite their proven e cacy, they are associated with a range of side effects and relatively poor adherence [11], and have potentially limited long-lasting effects [12], [13] [ 15].…”

Effectiveness of lifestyle interventions for improving the physical health of children and adolescents taking antipsychotic medications: protocol for a systematic review and meta-analysis

“…While there is some evidence that short-term antipsychotic use may reduce aggression and conduct problems in children and adolescents with disruptive behaviour disorders,14 16–19 antipsychotic medications carry a significant risk of adverse events that compromise ongoing health 1 14 20. These adverse events include metabolic disturbances, sedation/somnolence, prolactin elevation, sexual dysfunction, cardiological and haematological adverse events, neurological adverse events and even behavioural adverse events, including psychomotor retardation, anorexia, agitation or a lack of spontaneity 1 20.…”